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Natural killer (NK) cells are known as frontline responders capable of rapidly mediating a 
response upon encountering transformed or infected cells. Recent findings indicate that 
NK cells, in addition to acting as innate effectors, can also regulate adaptive immune 
responses. Here, we review recent studies on the immunoregulatory function of NK cells 
with a specific focus on their ability to affect the generation of early, as well as long-term 
antiviral T cell responses, and their role in modulating immune pathology and disease. 
In addition, we summarize the current knowledge of the factors governing regulatory 
NK cell responses and discuss origin, tissue specificity, and open questions about the 
classification of regulatory NK cells as classical NK cells versus group 1 innate lymphoid 
cells.
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inTRODUCTiOn
Natural killer (NK) cells were identified in the 1970s as natural effector cells with the capacity to lyse 
tumor cells (1, 2). The role of NK cells as effectors against transformed and virally infected cells has 
been well established (3). Regulated through a range of activating and inhibitory receptors (4), NK 
cell activation results in cytotoxic degranulation and the production of inflammatory cytokines, such 
as interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α) (5). While the importance of NK cells 
as frontline responders remains undisputed, regulatory functions of NK cells are being increasingly 
appreciated in several settings and especially in the regulation of immune responses during viral 
infections (6–12). A regulatory role of NK cells is also emerging in the context of reproduction 
[reviewed in Ref. (13)]. A major issue that is still to be resolved is the nature of these “natural immune 
regulators,” and whether they represent classical NK cells or a population of the recently defined 
innate lymphoid cells (ILCs).
iMPACT THROUGH CYTOKine AnD CHeMOKine PRODUCTiOn
Activated NK cells can express a number of secreted molecules that may augment or dampen 
immune responses. NK cell-derived IFN-γ and TNF-α have antiviral effects and play a role in the 
activation and/or maturation of dendritic cells (DCs) (14–16), macrophages, and T cells (5, 17). 
Moreover, NK cells can produce granulocyte-macrophage colony-stimulating factor (18), IL-5, IL-13 
(19), and IL-10 (6), thereby impacting various downstream immune responses. NK cells can also 
affect immune responses through the production of chemokines, such as CCL3, CCL4, and CCL5, 
which recruit other effector cells to sites of inflammation (20).
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iMPACT On DCs AnD THe PRiMinG OF 
ADAPTive iMMUne ReSPOnSeS
In addition to cytokine- and chemokine-mediated effects, 
NK cells can affect the priming of adaptive immune responses 
through killing of infected or transformed cells (7, 16, 21, 22). 
Early elimination of murine cytomegalovirus (MCMV)-infected 
cells through recognition of the viral protein m157 by Ly49H+ NK 
cells has been associated with decreased levels of type I IFN pro-
duction by plasmacytoid DCs (21). As a result, DCs were main-
tained in higher numbers, augmenting the very early priming of 
antiviral CD8+ T cell responses. However, this was a transient 
effect, as Ly49H+ NK cells also eliminate MCMV-infected DCs, 
ultimately reducing T cell priming and thereby curbing ongoing 
T cell responses (7).
Similarly, early depletion of NK cells in a mouse model of 
lymphocytic choriomeningitis virus (LCMV) infection improved 
DC priming of virus-specific T cells (11). Together, these studies 
establish a role for NK cells in the regulation of DCs and, as a 
consequence, the priming of adaptive T cell responses.
nK CeLLS AS DiReCT MODULATORS OF 
ADAPTive T CeLL-MeDiATeD iMMUniTY
As mentioned above, NK cells can contribute to the activation 
of T cells through the production of cytokines that promote 
T cell priming and differentiation (5). In addition, NK cells can 
express costimulatory molecules, such as OX40 ligand, allowing 
them to directly promote T cell proliferation (23). Direct NK cell-
mediated inhibition of T cell responses has also been reported. 
In this regard, a number of different in  vitro and in  vivo stud-
ies in human and mouse models have shown that NK cells are 
capable of directly killing T cells. An in  vitro approach study-
ing the role of human NK cells in the response to intracellular 
antigen revealed that activated NK cells can eliminate regulatory 
T cells (24). Direct elimination of effector CD4+ T cells by NK 
cells has been reported in mouse models of chronic inflamma-
tion (25) and graft-versus-host disease (26). Similarly, human NK 
cells have been reported capable of killing activated T cells (27, 
28). In vitro experiments investigating the sensitivity of T cells 
to NK cell-mediated killing revealed that, while resting T cells 
were resistant to lysis by NK cells, recently primed T cells were 
susceptible (29). Susceptibility to killing was limited to the first 
few days following T cell activation, and declined thereafter, with 
T cells regaining sensitivity to NK cell killing upon  re-encountering 
cognate antigen. The sensitivity of activated T cells was associated 
with the upregulation of ligands for the NK cell activating recep-
tor NKG2D. The role of NKG2D-mediated activities in the killing 
of T cells by NK cells in vivo is more complicated, with reports 
that NKG2D is both important (8, 9) or irrelevant (10, 30) being 
available. Furthermore, blocking inhibitory signals delivered 
upon engagement of the non-classical MHC I molecule Qa-1 
has been shown to allow the NK cell-mediated elimination of 
autoreactive T cells, resulting in reduced pathology in a model 
of experimental autoimmune encephalomyelitis (31). Although 
published studies mostly report NK cell-mediated effects on 
CD4+ T cells, suggesting that CD4+ T cells may be more sus-
ceptible to NK cell-mediated elimination, both CD4+ and CD8+  
T cells can be eliminated by NK cells, and this primarily involves 
perforin-dependent activities (8–10, 32). Elimination of T cells 
involving the TNF-related apoptosis-inducing ligand (TRAIL) 
(12, 27, 33) and Fas (26) has also been reported.
nK CeLLS in THe ReGULATiOn OF 
AnTiviRAL T CeLL ReSPOnSeS
Even though the interactions between NK cells and T cells have 
been studied in a number of different models, the most extensive 
investigations have been undertaken in the setting of viral infec-
tions. In this context, it is increasingly evident that, in addition 
to contributing to the elimination of infected cells, NK cells can 
also limit antiviral immunity (7, 9–12). Specifically, NK cells have 
been shown to impair both initial and ongoing antiviral T cell 
responses.
nK Cells as Regulators of early Antiviral  
T Cell immunity
A frequently used model to investigate the role of NK cells in 
viral infection is MCMV. The first indication that NK cells 
could modulate T cell responses came from studies showing 
that their depletion in C57BL/6 mice at the time of MCMV 
infection resulted in increased T cell proliferation and higher 
numbers of T cells expressing IFN-γ (34). This important find-
ing was extended by our studies showing that NK cells limited 
the function and longevity of antiviral T cell responses via the 
elimination of MCMV-infected DCs (7). Notably, the more robust 
antiviral T cell activities generated in the absence of early NK cell 
responses expedited the control of chronic MCMV infection (7). 
Furthermore, it has been reported that a mutation in the gene 
encoding the NK cell activating receptor NKp46, which leads to 
hyperreactivity of NK cells, results in suboptimal anti-MCMV 
T cell responses (35). Most recently, our studies have revealed an 
immune-regulatory function for NK cells in the salivary glands, 
a site of chronic MCMV infection (12). Viral control in the 
salivary glands is directly dependent on CD4+ T cells, with more 
robust antiviral CD4+ T cell responses resulting in accelerated 
viral control. Notably, CD4+ T cells accumulating in the salivary 
glands during chronic MCMV infection upregulate the recep-
tor for TRAIL, rendering them susceptible to TRAIL-mediated 
activities. These activities were found to be mediated by TRAIL 
on NK cells (12), with timed NK cell depletion or deficiency 
in TRAIL resulting in elevated numbers of antiviral CD4+  
T cells and enhanced viral control. The specific upregulation of 
NKG2D ligands on CD4+, but not CD8+ T cells, and the NKG2D 
expression on TRAIL+ NK cells provided strong support for an 
important role being mediated by these additional interactions in 
determining the fate of TRAIL-R+ CD4+ T cells upon encounter 
with TRAIL+ NK cells.
Similar to observations made for MCMV infection, there 
is accumulating evidence supporting a role for NK cells in 
the regulation of antiviral T cell responses to LCMV. A study 
investigating the role of the NK cell receptor 2B4, revealed that 
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2B4-deficient mice had reduced numbers of activated CD8+ 
T cells and  consequently prolonged viral persistence (32). This 
phenotype could be reverted by depletion of NK cells, indicating 
that the absence of 2B4 leads to NK cell-mediated elimination of 
LCMV-specific CD8+ T cells.
Further studies have supported the hypothesis that NK cells 
regulate T cell responses during both an acute and chronic LCMV 
infection. Following both types of LCMV infection, NK cells 
showed enhanced cytotoxicity and were capable of eliminating 
T cells that had been activated in vitro (9). Notably, in the absence 
of NK cells, LCMV infection resulted in increased frequencies 
of LCMV-specific CD8+ T cells, significantly reduced viral titers, 
and less virus-induced hepatitis, suggesting that NK cells pro-
mote the development of chronic infection (9). Protection against 
T cell exhaustion was also reported in the absence of NK cells 
(11). A concurrent study confirmed the regulatory effect of NK 
cells on the generation of antiviral T cell responses, immune 
pathology, and viral control (10). Here, however, the authors 
extended previous findings and reported that viral dose had a 
significant impact on how NK cells affected antiviral immune 
responses. The varying effects of NK cells in infections with dif-
ferent LCMV viral doses were due to changes in the patterns of 
T cell-mediated pathology. In mice infected with a high viral dose, 
NK cells prevented mortality but promoted viral persistence. Here, 
NK cell depletion resulted in elevated T cell numbers, reduced 
T cell exhaustion, but increased mortality, indicating a protective 
effect of NK cells in this setting. In contrast, the severe immune 
pathology associated with infection with a medium LCMV viral 
dose was abrogated by depletion of NK cells, and complete viral 
clearance was achieved with 100% survival. Although ultimately 
NK cells suppressed CD8+ T cell responses, the authors propose 
that this is mediated indirectly via the elimination of CD4+  
T cells (10).
Together, these studies clearly outline a role for NK cells in 
the regulation of primary T cell responses to viral infection and 
open the possibility that the regulatory effects of NK cells may 
also modulate long-term antiviral responses and the generation 
of memory.
Regulatory nK Affect Ongoing Antiviral  
T Cell immunity and Memory Generation
In MCMV infection, mice lacking the capacity to eliminate 
MCMV-infected DCs through Ly49H+ NK cells generated more 
robust T cell responses, with significant differences in both 
kinetics and functionality (7). Importantly, these differences 
are maintained in the long term, with stronger cytokine and 
chemokine expression and increased retention of leukocytes in 
tissues observed in mice lacking early Ly49H-mediated NK cell 
activities (unpublished observations, S. V. VanDommelen, Iona S. 
Schuster, Christopher E. Andoniou, Mariapia A. Degli-Esposti).
An effect on ongoing antiviral responses was also noted in 
MCMV-infected mice lacking TRAIL+ NK cells in the salivary 
glands (12). The lack of TRAIL+ NK cells resulted in increased 
accumulation of antiviral T cells and improved viral control 
in the salivary glands. However, the failure to restrain CD4+  
T cell responses was associated with an increase in autoantibody 
production, the formation of tertiary lymphoid-like structures, 
and, most importantly, the loss of tissue function in the affected 
exocrine glands indicating the development of an autoimmune 
disease with the characteristics of human Sjogren’s syndrome 
(12). These observations are of particular interest as this study 
provided the first evidence for a physiological effect of NK cell 
immune regulation, with NK cells playing a crucial role in main-
taining a balance between protective immunity and excessive 
pathologic or autoreactive immune responses.
Similar to MCMV infection, the immunomodulatory func-
tions of NK cells in LCMV infected mice not only affect early 
antiviral immune responses but also modulate ongoing antiviral 
immunity and the generation of immunological memory (11, 30, 
36). First indicators of the long-term effects of NK cells on anti-
LCMV T cell responses were the reduced frequencies of virus-
specific T cells in mice lacking the NK cell inhibitory receptor 
2B4 observed up to 100 days post-LCMV infection (32), and the 
observation that T cell exhaustion, as defined by PD-1 and Lag-3 
expression, was decreased in NK-cell depleted mice (11). Further 
studies demonstrated that NK cell depletion in the initial stages 
of acute LCMV infection, as well as Pichinde virus infection, 
specifically altered the generation of memory precursor effector 
cells and resulted in T cell memory with improved functional 
capacity (30). Furthermore, NK cell-depleted mice had elevated 
numbers of T follicular helper cells (Tfh) and germinal center 
B cells, resulting in more sustained antibody responses (30). 
The latter results were corroborated by data demonstrating that 
mice depleted of NK cells just before LCMV infection gener-
ated a more robust Tfh response facilitating greater germinal 
center B cell and plasmablast formation, elevated concentration 
of anti-LCMV antibodies, and improved control of chronic 
infection (36).
Overall, these studies form a strong body of evidence support-
ing the hypothesis that NK cells not only affect the generation 
of primary T cell responses to viral pathogens but also alter 
the quantity and quality of ongoing responses, including T and 
B cell memory responses and long-term protection. Although the 
NK cell-mediated moderation of both primary antiviral T cell 
responses and the ensuing generation of memory may at face 
value appear detrimental to the host, the development of autoim-
munity observed in mice lacking regulatory NK cell functions 
indicates that, in physiological settings, NK cells contribute to the 
balancing of immune responses (Figure 1).
Much remains to be understood about the immune-regulatory 
role of NK cells, including their impact on adaptive immunity at 
late stages of persistent viral infections. Interestingly, in a model 
of Friend retrovirus infection, NK cell depletion in the acute 
phase of infection impaired viral control, but depletion of NK 
cells during chronic infection led to increased numbers of acti-
vated CD8+ T cells and expedited viral control (37). A study by 
Peppa et al. (33) outlined a role for NK cells in limiting hepatitis 
B virus (HBV)-specific CD8+ T cell numbers. Analysis of PBMCs 
from chronically infected patients cultured in the presence or 
absence of NK cells showed increased numbers of activated CD8+ 
T cells in NK cell-depleted cultures. A significant upregulation 
of TRAIL receptor 2 (TRAIL-R2) was noted on hepatic CD8+ 
T cells from chronically HBV-infected patients, compared with 
FiGURe 1 | nK cell regulation of T cell immunity. NK cells can modulate the activities of T cells either indirectly, by eliminating, or affecting the functions of 
antigen-presenting cells, especially DCs, or through direct interactions with T cells themselves. During viral infections, these regulatory interactions can lead to 
differing outcomes depending on the infecting viral pathogen and the phase of the infection. During acute infection, NK cell regulation can dampen antiviral T cell 
responses (7, 9–11), lead to increased viral loads (9–11), and ultimately determine the extent of pathology in tissues (9, 10). In infections that have a chronic phase, 
NK cells can determine the longevity of the infection and indeed extend it (7, 11, 12, 33, 36). Memory T cell responses are generated at reduced frequencies (30), 
and antibody responses can be compromised due to impaired formation of germinal centers (30, 36). This apparently incongruous dampening of immune response 
is reconciled by the finding that curbing chronic immune responses following viral infections is critical to reducing the development of autoimmunity (12).
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healthy controls, and blocking TRAIL augmented the survival of 
hepatic CD8+ T cells cultured with PBMCs (33). These results 
indicate that the immune-regulatory functions of NK cells are 
not only restricted to mouse models of infection but are also 
observed in the human system. Whether NK cells play similar 
immunoregulatory activities in other settings of chronic disease 
remains to be described.
ReGULATinG THe ReGULATORS
Factors that modulate the regulatory functions of NK cells in 
inflammatory settings have recently been identified. NK cells 
from mice with a mutation in the gene for the NK cell activating 
receptor NKp46 failed to downregulate the transcription factor 
Helios, resulting in overly responsive NK cells, which in turn 
weakened T cell responses in inflammatory settings, such as 
viral infection (35). Other factors regulating the susceptibility of 
T cells to NK cell-mediated elimination include the transcrip-
tion regulator NOD-like receptor caspase recruitment domain 
containing protein 5 (NLRC5) (38). The absence of NLRC5 in 
activated T cells responding to different inflammatory stimuli 
resulted in significantly reduced MHC I expression and rendered 
these cells susceptible to NK cell killing. The susceptibility of 
T cells to NK cell killing can also be affected by type I IFN, and 
Ifnar1−/− T cells were found to have reduced expression of the 
NK cell inhibitory ligands MHC I and Qa-1b (39) and elevated 
expression of ligands for the NK cell activating receptor NKp46 
(40), leading to increased NK cell killing of LCMV-specific T cells.
ReGULATORY nK CeLLS: iLC1 veRSUS 
CLASSiCAL nK CeLLS
Even though immune-regulatory effects of NK cells are slowly 
being unraveled, many questions remain unanswered regarding 
the generation, phenotype, and tissue specificity of NK cells with 
immune-regulatory capacity. Addressing these questions has been 
complicated by the recent identification of novel populations of 
ILCs. NK cells have been classified as being a subclass of group 1 
ILCs (41). The group 1 ILCs are characterized by their expression 
of the T-box transcription factor T-bet, an ability to produce IFN-
γ, and an inability to produce TH2- and TH17-associated cytokines 
(41). The group 1 ILC can be subdivided into NK cells and ILC1, 
but the distinction between the subsets is hardly straightforward 
and appears to be tissue and activation dependent (42). In liver, 
at steady state, for example, ILC1 can be distinguished from NK 
cells by the expression of CD49a and TRAIL and a lack of CD49b 
expression and the transcription factor Eomesodermin (Eomes) 
(43, 44). NK cells are strongly cytotoxic and express high levels 
of perforin and granzymes, whereas ILC1 express low levels of 
perforin, but show increased expression of cytokines, including 
IFN-γ and especially TNF-α (43, 45). Despite reduced perforin 
expression, hepatic TRAIL+ NK cells were reported to kill tumor 
5Schuster et al. Natural Regulators
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cells in both a TRAIL-dependent and -independent manner 
(46) and appear to contribute to liver pathology in chronic HBV 
sufferers by eliminating hepatocytes (47, 48). Together, these 
data suggest that hepatic ILC1 cells may have a greater cytotoxic 
potential than currently assumed.
In addition to being found in the liver, ILC1 cells have been 
described in other tissues, including the gut, skin, uterus, and 
salivary glands (45, 49). Differentiating between NK cells and 
ILC1 is of particular interest in the salivary glands, where TRAIL+ 
NK cells limit anti-MCMV CD4+ T cell responses (12). Tessmer 
et  al. (50) described steady-state salivary gland NK cells as a 
phenotypically distinct population, based on their integrin and 
activation marker profile, with these cells unable to mount effi-
cient cytotoxic responses to various stimuli. Following MCMV 
infection, a lack of NK cell recruitment was noted, suggesting that 
the NK cell regulatory response in the salivary glands is medi-
ated by proliferation of tissue-resident cells. This characteristic of 
salivary gland NK cells is shared with ILC1 cells that are thought 
to be primarily tissue resident (45). These results differ from our 
own, where regulatory TRAIL+ NK cells seem to be recruited into 
the salivary glands in response to MCMV infection (12). Possible 
explanations for this disparity include differences in the timing of 
NK cell transfer, the strain of mouse, and/or the strain of MCMV 
used in the different experiments.
The ILC populations found in the salivary glands have phe-
notypic profiles consistent with both NK cells and ILC1 (49). 
Interestingly, the development of these cells under homeostatic 
conditions was found to be independent of the transcription fac-
tor Nfil3, suggesting that NK cells present in the salivary glands 
at steady state are ILC1 (49, 51). However, salivary gland NK 
cells express both T-bet and Eomes, consistent with an NK cell 
phenotype. Furthermore, under inflammatory conditions, such 
as viral infection, it appears that NK cells can be recruited to the 
salivary glands, and their phenotype does not conform to that 
of ILC1 (12). Thus, the regulatory NK cell population that bal-
ances protective antiviral immunity with potentially pathologic 
autoreactive immune responses appears to be classical NK cells. 
However, in their entirety, the available data suggest that a distinc-
tion between classical NK cells versus ILC1s may be very difficult 
especially in inflamed tissues, where cytokines can drastically 
alter the phenotype of these populations.
COnCLUSiOn
The collective data reviewed here establish that NK cells regulate 
adaptive responses both during priming and at later stages. 
Importantly, the regulatory functions of NK cells are not limited 
to interactions in lymphoid tissues but have been observed in 
non-lymphoid organs. An intriguing question yet to be answered 
is whether the regulation of adaptive immune responses in tissues 
is mediated by ILC1, NK cells or both subsets, and if there is any 
plasticity between these cell populations.
AUTHOR COnTRiBUTiOnS
All authors listed, have made substantial, direct and intellectual 
contribution to the work, and approved it for publication.
ACKnOwLeDGMenTS
We would like to thank Dr. N. Guerra for critical reading of the 
manuscript. MD-E and CA hold grants (MD-E and CA) and 
a Principal Research Fellowship (MD-E) from the NHMRC, 
Australia.
ReFeRenCeS
1. Herberman RB, Nunn ME, Holden HT, Lavrin DH. Natural cytotoxic reac-
tivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. 
Characterization of effector cells. Int J Cancer (1975) 16(2):230–9. doi:10.1002/
ijc.2910160205 
2. Kiessling R, Klein E, Wigzell H. “Natural” killer cells in the mouse. I. Cytotoxic 
cells with specificity for mouse Moloney leukemia cells. Specificity and distri-
bution according to genotype. Eur J Immunol (1975) 5(2):112–7. doi:10.1002/
eji.1830050208 
3. Cerwenka A, Lanier LL. Natural killer cells, viruses and cancer. Nat Rev 
Immunol (2001) 1(1):41–9. doi:10.1038/35095564 
4. Lanier LL. Up on the tightrope: natural killer cell activation and inhibition. 
Nat Immunol (2008) 9(5):495–502. doi:10.1038/ni1581 
5. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural 
killer cells. Nat Immunol (2008) 9(5):503–10. doi:10.1038/ni1582 
6. Lee SH, Kim KS, Fodil-Cornu N, Vidal SM, Biron CA. Activating receptors 
promote NK cell expansion for maintenance, IL-10 production, and CD8 
T cell regulation during viral infection. J Exp Med (2009) 206(10):2235–51. 
doi:10.1084/jem.20082387 
7. Andrews DM, Estcourt MJ, Andoniou CE, Wikstrom ME, Khong A, 
Voigt V, et  al. Innate immunity defines the capacity of antiviral T cells to 
limit persistent infection. J Exp Med (2010) 207(6):1333–43. doi:10.1084/
jem.20091193 
8. Soderquest K, Walzer T, Zafirova B, Klavinskis LS, Polić B, Vivier E, et  al. 
Cutting edge: CD8+ T cell priming in the absence of NK cells leads to 
enhanced memory responses. J Immunol (2011) 186(6):3304–8. doi:10.4049/
jimmunol.1004122 
9. Lang PA, Lang KS, Xu HC, Grusdat M, Parish IA, Recher M, et al. Natural 
killer cell activation enhances immune pathology and promotes chronic 
infection by limiting CD8+ T-cell immunity. Proc Natl Acad Sci U S A (2012) 
109(4):1210–5. doi:10.1073/pnas.1118834109 
10. Waggoner SN, Cornberg M, Selin LK, Welsh RM. Natural killer cells act 
as rheostats modulating antiviral T cells. Nature (2012) 481(7381):394–8. 
doi:10.1038/nature10624
11. Cook KD, Whitmire JK. The depletion of NK cells prevents T cell exhaus-
tion to efficiently control disseminating virus infection. J Immunol (2013) 
190(2):641–9. doi:10.4049/jimmunol.1202448 
12. Schuster IS, Wikstrom ME, Brizard G, Coudert JD, Estcourt MJ, Manzur M, 
et al. TRAIL+ NK cells control CD4+ T cell responses during chronic viral 
infection to limit autoimmunity. Immunity (2014) 41(4):646–56. doi:10.1016/j.
immuni.2014.09.013 
13. Moffett A, Colucci F. Uterine NK cells: active regulators at the maternal-fetal 
interface. J Clin Invest (2014) 124(5):1872–9. doi:10.1172/JCI68107 
14. Degli-Esposti MA, Smyth MJ. Close encounters of different kinds: dendritic 
cells and NK cells take centre stage. Nat Rev Immunol (2005) 5(2):112–24. 
doi:10.1038/nri1549 
15. Vitale M, Della Chiesa M, Carlomagno S, Pende D, Aricò M, Moretta L, et al. 
NK-dependent DC maturation is mediated by TNFalpha and IFNgamma 
released upon engagement of the NKp30 triggering receptor. Blood (2005) 
106(2):566–71. doi:10.1182/blood-2004-10-4035 
16. Andoniou CE, Coudert JD, Degli-Esposti MA. Killers and beyond: NK-cell-
mediated control of immune responses. Eur J Immunol (2008) 38(11):2938–42. 
doi:10.1002/eji.200838882 
17. Martín-Fontecha A, Thomsen LL, Brett S, Gerard C, Lipp M, Lanzavecchia A, 
et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma 
6Schuster et al. Natural Regulators
Frontiers in Immunology | www.frontiersin.org June 2016 | Volume 7 | Article 235
for T(H)1 priming. Nat Immunol (2004) 5(12):1260–5. doi:10.1038/ 
ni1138 
18. Souza-Fonseca-Guimaraes F, Parlato M, de Oliveira RB, Golenbock D, 
Fitzgerald K, Shalova IN, et al. Interferon-gamma and granulocyte/monocyte 
colony-stimulating factor production by natural killer cells involves different 
signaling pathways and the adaptor stimulator of interferon genes (STING). 
J Biol Chem (2013) 288(15):10715–21. doi:10.1074/jbc.M112.435602 
19. Hoshino T, Winkler-Pickett RT, Mason AT, Ortaldo JR, Young HA. IL-13 
production by NK cells: IL-13-producing NK and T cells are present in vivo 
in the absence of IFN-gamma. J Immunol (1999) 162(1):51–9. 
20. Sawaki J, Tsutsui H, Hayashi N, Yasuda K, Akira S, Tanizawa T, et al. Type 1 
cytokine/chemokine production by mouse NK cells following activation of 
their TLR/MyD88-mediated pathways. Int Immunol (2007) 19(3):311–20. 
doi:10.1093/intimm/dxl148 
21. Robbins SH, Bessou G, Cornillon A, Zucchini N, Rupp B, Ruzsics Z, et al. 
Natural killer cells promote early CD8 T cell responses against cytomegalovi-
rus. PLoS Pathog (2007) 3(8):e123. doi:10.1371/journal.ppat.0030123 
22. Cheng M, Chen Y, Xiao W, Sun R, Tian Z. NK cell-based immunotherapy 
for malignant diseases. Cell Mol Immunol (2013) 10(3):230–52. doi:10.1038/
cmi.2013.10 
23. Zingoni A, Sornasse T, Cocks BG, Tanaka Y, Santoni A, Lanier LL. Cross-
talk between activated human NK cells and CD4+ T cells via OX40-OX40 
ligand interactions. J Immunol (2004) 173(6):3716–24. doi:10.4049/
jimmunol.173.6.3716 
24. Roy S, Barnes PF, Garg A, Wu S, Cosman D, Vankayalapati R. NK cells lyse 
T regulatory cells that expand in response to an intracellular pathogen. 
J Immunol (2008) 180(3):1729–36. doi:10.4049/jimmunol.180.3.1729 
25. Fort MM, Leach MW, Rennick DM. A role for NK cells as regulators of CD4+ 
T cells in a transfer model of colitis. J Immunol (1998) 161(7):3256–61. 
26. Noval Rivas M, Hazzan M, Weatherly K, Gaudray F, Salmon I, Braun MY. NK 
cell regulation of CD4 T cell-mediated graft-versus-host disease. J Immunol 
(2010) 184(12):6790–8. doi:10.4049/jimmunol.0902598 
27. Nielsen N, Ødum N, Ursø B, Lanier LL, Spee P. Cytotoxicity of CD56(bright) 
NK cells towards autologous activated CD4+ T cells is mediated through 
NKG2D, LFA-1 and TRAIL and dampened via CD94/NKG2A. PLoS One 
(2012) 7(2):e31959. doi:10.1371/journal.pone.0031959 
28. Cerboni C, Zingoni A, Cippitelli M, Piccoli M, Frati L, Santoni A. Antigen-
activated human T lymphocytes express cell-surface NKG2D ligands via an 
ATM/ATR-dependent mechanism and become susceptible to autologous 
NK-cell lysis. Blood (2007) 110(2):606–15. doi:10.1182/blood-2006-10-052720 
29. Rabinovich BA, Li J, Shannon J, Hurren R, Chalupny J, Cosman D, et  al. 
Activated, but not resting, T cells can be recognized and killed by syngeneic 
NK cells. J Immunol (2003) 170(7):3572–6. doi:10.4049/jimmunol.170.7.3572 
30. Rydyznski C, Daniels KA, Karmele EP, Brooks TR, Mahl SE, Moran MT, et al. 
Generation of cellular immune memory and B-cell immunity is impaired by 
natural killer cells. Nat Commun (2015) 6:6375. doi:10.1038/ncomms7375 
31. Lu L, Ikizawa K, Hu D, Werneck MB, Wucherpfennig KW, Cantor H. Regulation 
of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory path-
way. Immunity (2007) 26(5):593–604. doi:10.1016/j.immuni.2007.03.017 
32. Waggoner SN, Taniguchi RT, Mathew PA, Kumar V, Welsh RM. Absence of 
mouse 2B4 promotes NK cell-mediated killing of activated CD8+ T cells, 
leading to prolonged viral persistence and altered pathogenesis. J Clin Invest 
(2010) 120(6):1925–38. doi:10.1172/JCI41264 
33. Peppa D, Gill US, Reynolds G, Easom NJ, Pallett LJ, Schurich A, et  al. 
Up-regulation of a death receptor renders antiviral T cells susceptible to 
NK cell-mediated deletion. J Exp Med (2013) 210(1):99–114. doi:10.1084/
jem.20121172 
34. Su HC, Nguyen KB, Salazar-Mather TP, Ruzek MC, Dalod MY, Biron CA. NK 
cell functions restrain T cell responses during viral infections. Eur J Immunol 
(2001) 31(10):3048–55. doi:10.1002/1521-4141(2001010)31:10<3048::AID- 
IMMU3048>3.0.CO;2-1 
35. Narni-Mancinelli E, Jaeger BN, Bernat C, Fenis A, Kung S, De Gassart A, 
et al. Tuning of natural killer cell reactivity by NKp46 and Helios calibrates 
T cell responses. Science (2012) 335(6066):344–8. doi:10.1126/science. 
1215621 
36. Cook KD, Kline HC, Whitmire JK. NK cells inhibit humoral immunity by 
reducing the abundance of CD4+ T follicular helper cells during a chronic virus 
infection. J Leukoc Biol (2015) 98(2):153–62. doi:10.1189/jlb.4HI1214-594R 
37. Littwitz E, Francois S, Dittmer U, Gibbert K. Distinct roles of NK cells in 
viral immunity during different phases of acute Friend retrovirus infection. 
Retrovirology (2013) 10:127. doi:10.1186/1742-4690-10-127 
38. Ludigs K, Jandus C, Utzschneider DT, Staehli F, Bessoles S, Dang AT, et al. 
NLRC5 shields T lymphocytes from NK-cell-mediated elimination under 
inflammatory conditions. Nat Commun (2016) 7:10554. doi:10.1038/
ncomms10554 
39. Xu HC, Grusdat M, Pandyra AA, Polz R, Huang J, Sharma P, et  al. Type I 
interferon protects antiviral CD8+ T cells from NK cell cytotoxicity. Immunity 
(2014) 40(6):949–60. doi:10.1016/j.immuni.2014.05.004 
40. Crouse J, Bedenikovic G, Wiesel M, Ibberson M, Xenarios I, Von Laer D, 
et  al. Type I interferons protect T cells against NK cell attack mediated by 
the activating receptor NCR1. Immunity (2014) 40(6):961–73. doi:10.1016/j.
immuni.2014.05.003 
41. Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, et al. Innate 
lymphoid cells  –  a proposal for uniform nomenclature. Nat Rev Immunol 
(2013) 13(2):145–9. doi:10.1038/nri3365 
42. Seillet C, Belz GT. Differentiation and diversity of subsets in group 1 innate 
lymphoid cells. Int Immunol (2016) 28(1):3–11. doi:10.1093/intimm/
dxv051 
43. Gordon SM, Chaix J, Rupp LJ, Wu J, Madera S, Sun JC, et  al. The tran-
scription factors T-bet and Eomes control key checkpoints of natural 
killer cell maturation. Immunity (2012) 36(1):55–67. doi:10.1016/j.
immuni.2011.11.016 
44. Yokoyama WM, Sojka DK, Peng H, Tian Z. Tissue-resident natural killer 
cells. Cold Spring Harb Symp Quant Biol (2013) 78:149–56. doi:10.1101/
sqb.2013.78.020354 
45. Sojka DK, Plougastel-Douglas B, Yang L, Pak-Wittel MA, Artyomov MN, 
Ivanova Y, et  al. Tissue-resident natural killer (NK) cells are cell lineages 
distinct from thymic and conventional splenic NK cells. Elife (2014) 3:e01659. 
doi:10.7554/eLife.01659 
46. Takeda K, Hayakawa Y, Smyth MJ, Kayagaki N, Yamaguchi N, Kakuta S, et al. 
Involvement of tumor necrosis factor-related apoptosis-inducing ligand in 
surveillance of tumor metastasis by liver natural killer cells. Nat Med (2001) 
7(1):94–100. doi:10.1038/83416 
47. Ochi M, Ohdan H, Mitsuta H, Onoe T, Tokita D, Hara H, et al. Liver NK cells 
expressing TRAIL are toxic against self hepatocytes in mice. Hepatology (2004) 
39(5):1321–31. doi:10.1002/hep.20204 
48. Dunn C, Brunetto M, Reynolds G, Christophides T, Kennedy PT, Lampertico 
P, et al. Cytokines induced during chronic hepatitis B virus infection promote a 
pathway for NK cell-mediated liver damage. J Exp Med (2007) 204(3):667–80. 
doi:10.1084/jem.20061287 
49. Cortez VS, Fuchs A, Cella M, Gilfillan S, Colonna M. Cutting edge: salivary 
gland NK cells develop independently of Nfil3 in steady-state. J Immunol 
(2014) 192(10):4487–91. doi:10.4049/jimmunol.1303469 
50. Tessmer MS, Reilly EC, Brossay L. Salivary gland NK cells are phenotypically 
and functionally unique. PLoS Pathog (2011) 7(1):e1001254. doi:10.1371/
journal.ppat.1001254 
51. Seillet C, Huntington ND, Gangatirkar P, Axelsson E, Minnich M, Brady 
HJ, et  al. Differential requirement for Nfil3 during NK cell development. 
J Immunol (2014) 192(6):2667–76. doi:10.4049/jimmunol.1302605 
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be 
construed as a potential conflict of interest.
Copyright © 2016 Schuster, Coudert, Andoniou and Degli-Esposti. This is an open-ac-
cess article distributed under the terms of the Creative Commons Attribution License 
(CC BY). The use, distribution or reproduction in other forums is permitted, provided 
the original author(s) or licensor are credited and that the original publication in this 
journal is cited, in accordance with accepted academic practice. No use, distribution 
or reproduction is permitted which does not comply with these terms.
